NASDAQ:ATRA | Insider Transactions — Page 8 | Atara Biotherapeutics, Inc.

ATRA Insider Transactions — Page 8

717 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 701–717; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
MARCUS JOEL SDirector2014-10-21Purchase9,090.0$11.0
Gallagher Carol GiltnerDirector2014-10-21Purchase18,181.0$11.0
MARCUS JOEL SDirector2014-10-21Purchase150,000.0$11.0
TREU JESSE ITenPercentOwner2014-10-21Purchase1,841.0$11.0
BLAIR JAMES CTenPercentOwner2014-10-21Purchase1,841.0$11.0
VITULLO NICOLETenPercentOwner2014-10-21Purchase1,841.0$11.0
DOVEY BRIAN HTenPercentOwner2014-10-21Purchase1,841.0$11.0
SCHOEMAKER KATHLEEN KTenPercentOwner2014-10-21Purchase1,841.0$11.0
Halak Brian KTenPercentOwner2014-10-21Purchase1,841.0$11.0
DP VIII Associates, L.P.TenPercentOwner2014-10-21Purchase1,841.0$11.0
TREU JESSE ITenPercentOwner2014-10-21Purchase248,159.0$11.0
BLAIR JAMES CTenPercentOwner2014-10-21Purchase248,159.0$11.0
VITULLO NICOLETenPercentOwner2014-10-21Purchase248,159.0$11.0
DOVEY BRIAN HTenPercentOwner2014-10-21Purchase248,159.0$11.0
SCHOEMAKER KATHLEEN KTenPercentOwner2014-10-21Purchase248,159.0$11.0
Halak Brian KTenPercentOwner2014-10-21Purchase248,159.0$11.0
Domain Partners VIII, L.P.TenPercentOwner2014-10-21Purchase248,159.0$11.0